BPC-157 Dosage Guide: Protocols, Routes, and How to Use It Safely
At a Glance
- Typical dose: 200-800 mcg/day for most adults, split into 1-2 administrations
- Routes: Subcutaneous injection (most studied), oral (gut-specific), intramuscular
- Cycle length: 4-6 weeks on, 2-4 weeks off is the most common protocol
- Reconstitution: Bacteriostatic water; store refrigerated once mixed
- Stacking: Frequently paired with TB-500 for synergistic tissue repair
What Is BPC-157 and Why Does Dosing Matter?
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in human gastric juice. In animal studies, it has shown remarkable ability to accelerate healing of tendons, ligaments, muscle, gut lining, and even bone. But the peptide itself is only half the equation. Getting the dose, route, and timing right determines whether you see real results or waste your money.
This guide breaks down the evidence-based protocols practitioners and researchers use, the differences between subcutaneous and oral dosing, how to reconstitute and inject safely, and how stacking with TB-500 may amplify outcomes. For a full overview of this peptide, see our complete BPC-157 guide.
Subcutaneous vs. Oral BPC-157: Choosing Your Route
The route you choose depends on what you are trying to heal. This is not a one-size-fits-all decision.
Subcutaneous Injection
Subcutaneous (subQ) injection is the most commonly studied route in animal research and the most popular among practitioners. The peptide enters the bloodstream relatively quickly and can exert systemic effects. If your target is a joint, tendon, ligament, or muscle injury, subQ injection near the site of injury is the standard recommendation.
Advantages: higher bioavailability, ability to inject close to the injury site, well-studied in preclinical models. Drawbacks: requires reconstitution, needles, and proper sterile technique.
Oral Administration
BPC-157 is one of the rare peptides that appears to retain biological activity when taken orally. This makes sense given its origin: it is derived from gastric juice proteins that naturally exist in the GI tract. Oral dosing is particularly relevant for gut-related conditions such as inflammatory bowel disease, leaky gut, gastric ulcers, and NSAID-induced GI damage.
Advantages: no needles, convenient, may be superior for GI healing. Drawbacks: lower systemic bioavailability, less studied for musculoskeletal targets.
| Factor | Subcutaneous Injection | Oral Administration |
|---|---|---|
| Best for | Tendons, ligaments, joints, muscle | Gut lining, GI inflammation, ulcers |
| Bioavailability | High (systemic) | Lower systemic; high local GI |
| Typical dose | 200-400 mcg, 1-2x daily | 250-500 mcg, 1-2x daily |
| Ease of use | Moderate (requires reconstitution) | Easy (capsule or liquid) |
| Onset of effects | Often within 1-2 weeks | Often within 1-3 weeks for GI |
BPC-157 Dosing by Body Weight
The most commonly referenced dosing range in preclinical research is roughly 1-10 mcg per kilogram of body weight per day. Practitioners have translated this into human-equivalent doses. Here is a general framework:
- Under 150 lbs (68 kg): 200-400 mcg/day
- 150-200 lbs (68-91 kg): 300-600 mcg/day
- Over 200 lbs (91 kg): 400-800 mcg/day
These ranges reflect practitioner consensus, not FDA-approved dosing. Start at the lower end and adjust based on response.
Most people split the daily dose into two administrations: once in the morning and once in the evening. Some practitioners recommend a single daily dose for simplicity, especially at the lower end of the range.
Cycling Protocols: How Long to Run BPC-157
Running BPC-157 indefinitely is not standard practice. Cycling helps prevent receptor desensitization and allows your body to consolidate healing gains.
Standard Protocol
4 weeks on, 2 weeks off. This is the most widely recommended cycle for general musculoskeletal injuries. After the off period, reassess. Many people find that one or two cycles are sufficient for mild to moderate injuries.
Extended Protocol
6 weeks on, 2-4 weeks off. Used for more severe or chronic injuries, post-surgical recovery, or stubborn tendinopathies. Some practitioners extend to 8 weeks for complex cases, though this is less common.
Gut Healing Protocol
6-8 weeks of oral BPC-157, sometimes combined with other gut-supportive interventions. GI conditions often require longer protocols because mucosal healing is a slower process. Reassess symptoms and, if needed, run a second cycle after a 2-4 week break.
How to Reconstitute BPC-157
BPC-157 typically comes as a lyophilized (freeze-dried) powder in a vial, usually containing 5 mg. You will need bacteriostatic water (BAC water), insulin syringes, and alcohol swabs.
Step 1: Clean the tops of both the BPC-157 vial and the BAC water vial with alcohol swabs.
Step 2: Draw your desired amount of BAC water into the syringe. A common reconstitution is 2 mL of BAC water into a 5 mg vial. This gives you 2,500 mcg per mL, or 250 mcg per 0.1 mL (10 units on an insulin syringe).
Step 3: Inject the BAC water into the BPC-157 vial slowly, aiming the stream along the glass wall. Do not spray it directly onto the powder. Let it dissolve gently. Do not shake the vial.
Step 4: Once fully dissolved, store the vial in the refrigerator. Reconstituted BPC-157 is generally considered stable for about 3-4 weeks when refrigerated.
| BAC Water Added | Concentration | 250 mcg = | 500 mcg = |
|---|---|---|---|
| 1 mL | 5,000 mcg/mL | 5 units | 10 units |
| 2 mL | 2,500 mcg/mL | 10 units | 20 units |
| 3 mL | 1,666 mcg/mL | 15 units | 30 units |
Injection Sites and Technique
For subcutaneous injection, the general principle is to inject as close to the injury site as practical. You are not injecting into the joint or tendon itself; you are injecting into the fatty tissue nearby.
Common injection sites:
- Shoulder injuries: Subcutaneous injection into the deltoid area or surrounding tissue
- Knee injuries: Fatty tissue around the knee, just below or to the side of the kneecap
- Achilles/ankle: Subcutaneous tissue near the Achilles tendon
- Elbow (tennis/golfer’s elbow): Subcutaneous tissue near the lateral or medial epicondyle
- Abdominal injection: For systemic effects or when the injury site is difficult to reach, the lower abdominal fat pad works well
Use a 29-31 gauge insulin syringe. Pinch the skin, insert the needle at a 45-degree angle, inject slowly, and withdraw. Rotate injection sites to avoid irritation.
Stacking BPC-157 with TB-500
TB-500 (Thymosin Beta-4) is another peptide with tissue repair properties. Where BPC-157 works primarily through growth factor modulation and angiogenesis, TB-500 promotes cell migration and reduces inflammation through different pathways. The two are frequently combined because their mechanisms complement each other.
A typical stacking protocol:
| Peptide | Loading Phase (Weeks 1-2) | Maintenance (Weeks 3-6) |
|---|---|---|
| BPC-157 | 250-500 mcg, 2x daily | 250-500 mcg, 1x daily |
| TB-500 | 2-2.5 mg, 2x per week | 2-2.5 mg, 1x per week |
They can be injected at the same time (in the same syringe or separate syringes at the same site). Many practitioners report that the combination produces faster and more complete healing than either peptide alone, though controlled human trials comparing the stack to monotherapy are lacking. Learn more about peptide combinations in our peptide therapy guide.
Safety Considerations and Side Effects
BPC-157 has a strong safety profile in preclinical research. No lethal dose has been identified in animal studies, which is unusual for a bioactive compound. That said, human clinical data is still limited. Reported side effects are generally mild:
- Mild nausea (more common with oral dosing)
- Injection site redness or irritation
- Dizziness (rare)
- Headache (rare)
Because BPC-157 promotes angiogenesis (new blood vessel formation), individuals with active cancer or a history of cancer should exercise caution and consult an oncologist before use. The same applies to anyone on blood thinners or with clotting disorders.
Where to Source BPC-157
Quality matters enormously with peptides. The market includes everything from pharmaceutical-grade compounded peptides to research-grade products of questionable purity. Look for third-party certificates of analysis (COA) with HPLC purity testing. Compounding pharmacies that operate under state or federal oversight are generally the safest source. Avoid products sold as “research chemicals” without clear purity documentation.
Frequently Asked Questions
Can I take BPC-157 on an empty stomach?
Yes. For oral dosing, taking it on an empty stomach may actually be preferable, as food can interfere with absorption. For injectable BPC-157, food intake does not matter.
How quickly does BPC-157 start working?
Many users report noticeable improvement within 1-2 weeks. Gut-related applications may take slightly longer. Severe or chronic injuries may require a full 4-6 week cycle before significant changes appear.
Is BPC-157 legal?
BPC-157 is not FDA-approved for any medical use. It exists in a gray area: it can be obtained through compounding pharmacies with a prescription in some jurisdictions, or purchased as a “research chemical.” Regulations vary by country. In the U.S., the FDA has expressed concern about peptides sold without prescriptions.
Can I use BPC-157 after surgery?
Some practitioners recommend BPC-157 post-operatively to support tissue healing. Timing varies, but starting a few days after surgery (once bleeding risk has subsided) is a common approach. Always discuss with your surgeon first.
Do I need to refrigerate BPC-157?
Lyophilized (powder) BPC-157 is stable at room temperature for extended periods, though refrigeration extends shelf life. Once reconstituted with bacteriostatic water, it must be refrigerated and used within 3-4 weeks.
Can BPC-157 and TB-500 be mixed in the same syringe?
Yes. Many users draw both peptides into a single insulin syringe and inject together. There is no known interaction that degrades either compound when combined.
